Assessment of the Relationship Between Gastric-Acid Suppressants and the Risk of Esophageal Adenocarcinoma: A Systematic Review and Meta-Analysis

Assessment of the Relationship Between Gastric-Acid Suppressants and the Risk of Esophageal Adenocarcinoma: A Systematic Review and Meta-Analysis

ABSTRACT: Background: Esophageal cancer is a cancerous tumor that develops in the esophagus. It is the 10th most common cancer and has a low survival rate. Esophageal adenocarcinoma (EAC) is increasing in incidence globally. Those with EAC are affected by Barrett's esophagus metaplasia, which...

Full description

Bibliographic Details
Main Authors:	Karamali Kasiri, Associate, Catherine M.T. Sherwin, Professor, Sahar Rostamian, MD, Saeid Heidari-Soureshjani, MSc
Format:	Article
Language:	English
Published:	Elsevier 2023-01-01
Series:	Current Therapeutic Research
Subjects:	esophageal adenocarcinoma gastric acid histamine-2 receptor antagonists oncology proton pump inhibitors
Online Access:	http://www.sciencedirect.com/science/article/pii/S0011393X23000024

Similar Items

History and Pharmacological Mechanism of Gastric Acid-suppressive Drugs
by: Dong Han Yeom, et al.
Published: (2023-09-01)

Algorithm for pharmacists from community pharmacies who dispense over-the-counter proton pump inhibitors and histamine receptor antagonists for patients reporting symptoms of reflux
by: Elżbieta Jaworska, et al.
Published: (2024-01-01)

The Prognostic Impact of Histology in Esophageal and Esophago-Gastric Junction Adenocarcinoma
by: Roberto Fiocca, et al.
Published: (2021-10-01)

Comparative analysis of the effect of IV administered acid suppressants on gastric pH in dogs
by: Amanda Kuhl, et al.
Published: (2020-03-01)

Esophageal Adenocarcinoma: An Unusual Pericardial and Pulmonary Metastasis – A Case Report
by: Waqas Rasheed, et al.
Published: (2023-10-01)

Prediction of Ventilator-Associated Pneumonia in Patients Undergoing Stress Ulcer Prophylaxis: A Longitudinal Descriptive Study in Iran
by: Shahriar Nikpour, et al.
Published: (2020-11-01)

Effects of Gastric Acid Secretion Inhibitors for Ventilator-Associated Pneumonia
by: Fang Li, et al.
Published: (2022-05-01)

Prognostic impact of activin subunit inhibin beta A in gastric and esophageal adenocarcinomas
by: J. J. Staudacher, et al.
Published: (2022-09-01)

COMPARISON OF THE EFFICACIES OF PROTON PUMP INHIBITORS AND H2 RECEPTOR ANTAGONISTS IN ON-DEMAND TREATMENT OF GASTROESOPHAGEAL REFLUX DISEASE
by: Nesibe Vardı, et al.
Published: (2018-08-01)

The association between gastric acid inhibitors and delirium in geriatric inpatients: implications for clinical practice and research
by: Zhu LL, et al.
Published: (2016-06-01)

Esophageal perforation secondary to malignant gastric outlet obstruction: a case report
by: Helen M. Johnson, et al.
Published: (2019-02-01)

Drug–Drug Interactions, Medication Adherence, and Stroke Should Be Considered When Approaching the Impact of Acid Suppression Therapy on Chronic Kidney Disease Patients. Comment on Chen et al. Impact of Acid Suppression Therapy on Renal and Survival Outcomes in Patients with Chronic Kidney Disease: A Taiwanese Nationwide Cohort Study. <i>J. Clin. Med.</i> 2022, <i>11</i>, 5612
by: Ai-Hsien Li, et al.
Published: (2022-12-01)

Indication of acid suppression therapy and predictors for the prophylactic use of proton-pump inhibitors vs. histamine-2 receptor antagonists in a Malaysian tertiary hospital
by: Oh AL, et al.
Published: (2015-09-01)

Effect of esophageal distention on basal and stimulated gastric acid secretion in rats
by: Mohammad Kazem Gharib Nasery, et al.
Published: (2007-02-01)

A Review of Tertiary Referrals for Management of Pediatric Esophageal Eosinophilia
by: Bridget Godwin, et al.
Published: (2018-06-01)

Two cases of esophageal eosinophilia: eosinophilic esophagitis or gastro-esophageal reflux disease?
by: Ozlem Yilmaz, et al.
Published: (2014-06-01)

Assessment of effectiveness of different dosage regimens of pantoprazole in controlling symptoms and healing esophageal lesions of patients with mild erosive esophagitis
by: Luciana Dias MORETZSOHN, et al.
Published: (2002-04-01)

Metastatic gastric adenocarcinoma to the uterine cervix—a case report and review of the literature
by: Vishal Bahall, et al.
Published: (2022-06-01)

Proton Pump Inhibitors (PPIs): The culprit for Barrett’s esophagus?
by: Omran eAlsalahi, et al.
Published: (2015-01-01)

Acid Suppressive Drugs
by: Cheol Min Shin
Published: (2022-06-01)

Acid-Suppressive Drugs and Risk of Fracture in Children and Young Adults: A Meta-Analysis of Observational Studies
by: Jiangbi Li, et al.
Published: (2021-08-01)

Impact of proton pump inhibitor management committee’s multifaceted interventions on acid suppressant prescribing patterns in outpatient and emergency departments
by: Lu Liu, et al.
Published: (2022-03-01)

Diagnosis and Treatment of Eosinophilic Esophagitis
by: Su Jin Kim, et al.
Published: (2022-03-01)

Effect of proton pump inhibitors in infants with esophageal atresia on the gut microbiome: a pilot cohort
by: Nele Brusselaers, et al.
Published: (2022-12-01)

Epstein-Barr virus in gastro-esophageal adenocarcinomas – single center experiences in the context of current literature.
by: Vera eGenitsch, et al.
Published: (2015-03-01)

Successes and failures of angiogenesis blockade in gastric and gastro-esophageal junction adenocarcinoma
by: Massimiliano Salati, et al.
Published: (2022-09-01)

Gastric Adenocarcinoma: A Multimodal Approach
by: Humair S. Quadri, et al.
Published: (2017-08-01)

Cervical esophageal adenocarcinoma of intestinal type in ectopic gastric mucosa
by: Ryosuke Ikeda, et al.
Published: (2023-04-01)

High prevalence of response to PPI treatment in children and adolescents with eosinophilic esophagitis in southern Brazil
by: Luiza Salgado Nader, et al.
Published: (2024-04-01)

The combined use of anti-peptic agents is associated with an increased risk of osteoporotic fracture: a nationwide case-control study
by: Dong Jun Oh, et al.
Published: (2024-03-01)

HISTORICAL PERSPECTIVE OF GASTROESOPHAGEAL REFLUX DISEASE CLINICAL TREATMENT
by: Schlioma ZATERKA, et al.

Pre-existing Proton Pump Inhibitor Treatment and Short-Term Prognosis of Acute Myocardial Infarction Patients
by: Juntao Xie, et al.
Published: (2022-07-01)

Corrigendum: Pre-existing proton pump inhibitor treatment and short-term prognosis of acute myocardial infarction patients
by: Juntao Xie, et al.
Published: (2022-07-01)

Proton Pump Inhibitors and Gastric Cancer
by: Seungkyung Kang, et al.
Published: (2021-09-01)

Potential immunological consequences of pharmacological suppression of gastric acid production in patients with multiple sclerosis
by: Biswas Sangita, et al.
Published: (2012-06-01)

Laparoscopic gastrectomy for gastric adenocarcinoma: Long-term results Gastrectomía laparoscópica por adenocarcinoma gástrico: Resultados a largo plazo
by: F. J. Ibáñez Aguirre, et al.
Published: (2006-06-01)

PROTON PUMP INHIBITORS DISPLAY ANTITUMOR EFFECTS IN BARRETT’S ADENOCARCINOMA CELLS
by: Eduardo Chueca, et al.
Published: (2016-11-01)

Effects of administration of omeprazole on the esophageal microbiota composition in rat model with reflux esophagitis
by: GAO Feng, JIA Meng-zhen, SUN Yue
Published: (2021-03-01)

Suppression of wheal and flare in histamine test by the main H1 antihistamines commercialized in Brazil
by: Helena Maciel-Guerra, et al.
Published: (2018-03-01)

Synchronous occurrence of hereditary gastric adenocarcinoma, gastrointestinal stromal tumor, and esophageal small cell and squamous carcinoma in situ: an extremely rare case report
by: Huijie Fan, et al.
Published: (2017-11-01)